BACKGROUND	In an International Breast Cancer Study Group ( IBCSG ) randomized clinical trial ( Trial VIII ) for pre - and perimenopausal women with lymph node-negative breast cancer , we compared sequential chemotherapy followed by the gonadotropin-releasing hormone agonist goserelin with each modality alone .\